| Accession Number: | 0001209191-22-027669 |
| Date: | 2022-05-05 |
| Issuer: | NURIX THERAPEUTICS, INC. (NRIX) |
| Original Submission Date: |
SILVA PAUL M
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DIRECTOR STOCK OPTION (RIGHT TO BUY) | 10.39 | 2022-05-05 | deemed execution date | A | 17,500 (a) | 2032-05-04 | common stock 17,500 | $10.39 | 17,500 | direct |
| ID | footnote |
|---|---|
| f1 | the stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the issuer's stockholders and (b) may 5, 2023, in each case, subject to the reporting person's provision of service to the issuer on such vesting date. |
